New therapies in nonmuscle invasive bladder cancer treatment.

INTRODUCTION

Nonmuscle invasive bladder cancer (NMIBC) remains a very challenging disease to treat with high rates of recurrence and progression associated with current therapies. Recent technological and biological advances have led to the development of novel agents in NMIBC therapy.

METHODS

We reviewed existing literature as well as currently active and recently completed clinical trials in NMIBC by querying PubMed.gov and clinicaltrials.gov.

RESULTS

A wide variety of new therapies in NMIBC treatment are currently being developed, utilizing recent developments in the understanding of immune therapies and cancer biology.

CONCLUSION

The ongoing efforts to develop new therapeutic approaches for NMIBC look very promising and are continuing to evolve.